Viewing Study NCT04506320

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:12 AM
Ignite Modification Date: 2026-01-29 @ 5:23 PM
Study NCT ID: NCT04506320
Status: COMPLETED
Last Update Posted: 2023-10-05
First Post: 2020-08-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma
Sponsor: Gruppo Italiano Trapianto di Midollo Osseo
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
None Stem Cell Transplant View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Allogeneic haematopoietic stem cell transplantation View
None Multiple Myeloma View
None Immuno-modulating agents View
None Protesome inhibitors View
None Monoclonal antibodies View